Literature DB >> 14715766

Assessment of agreement between the AMPLICOR HIV-1 MONITOR test versions 1.0 and 1.5.

Charles E Hill1, Alicia M Green, Jessica Ingersoll, Kirk A Easley, Frederick S Nolte, Angela M Caliendo.   

Abstract

The agreement of the microwell plate AMPLICOR HIV-1 MONITOR version 1.0 (MWP 1.0), the microwell plate AMPLICOR HIV-1 MONITOR version 1.5 (MWP 1.5), and the COBAS AMPLICOR HIV-1 MONITOR version 1.5 (COBAS 1.5) tests was evaluated using clinical specimens and well-characterized control material. Two hundred patient plasma specimens and a panel of known human immunodeficiency virus type 1 (HIV-1) subtypes were tested. All data were log(10) transformed prior to analysis. The 95% limits of agreement for the three tests at the average of 3.66 log(10) copies/ml were +/- 0.28 log(10), +/- 0.34 log(10), and +/- 0.34 log(10) copies/ml for MWP 1.0-MWP 1.5, MWP 1.0-COBAS 1.5, and MWP 1.5-COBAS 1.5, respectively. Ten specimens (6.1%) had differences exceeding the limits of agreement for the MWP 1.0 and MWP 1.5 tests. Correlation coefficients among the three tests were high (r >or=0.96). The viral-load values obtained with the MWP 1.0 test were only 2.1% higher on average than those measured with the MWP 1.5 test and 1.6% higher than those seen with the COBAS 1.5 test. The MWP 1.5 test values were 0.8% higher than the COBAS 1.5 test values. Overall, there was less agreement among the different tests for viral-load values near the lower limit of quantification. The MWP 1.0 test underquantified subtypes A, E, F, G, and H by 1.0 to 2.0 log(10) copies/ml; this problem was not observed with the MWP 1.5 test. The close agreement among the results obtained with the different test versions and formats suggests that it is not necessary to reestablish a baseline viral load when changing AMPLICOR HIV-1 MONITOR tests, unless the patient is known to be infected with a non-B subtype.

Entities:  

Mesh:

Year:  2004        PMID: 14715766      PMCID: PMC321658          DOI: 10.1128/JCM.42.1.286-289.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  Impact of HIV type 1 subtype variation on viral RNA quantitation.

Authors:  B Parekh; S Phillips; T C Granade; J Baggs; D J Hu; R Respess
Journal:  AIDS Res Hum Retroviruses       Date:  1999-01-20       Impact factor: 2.205

Review 2.  Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics.

Authors:  J Lew; P Reichelderfer; M Fowler; J Bremer; R Carrol; S Cassol; D Chernoff; R Coombs; M Cronin; R Dickover; S Fiscus; S Herman; B Jackson; J Kornegay; A Kovacs; K McIntosh; W Meyer; N Michael; L Mofenson; J Moye; T Quinn; M Robb; M Vahey; B Weiser; T Yeghiazarian
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

3.  Comparison of NucliSens and Roche Monitor assays for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma.

Authors:  J R Dyer; C D Pilcher; R Shepard; J Schock; J J Eron; S A Fiscus
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

4.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

5.  Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories.

Authors:  B Yen-Lieberman; D Brambilla; B Jackson; J Bremer; R Coombs; M Cronin; S Herman; D Katzenstein; S Leung; H J Lin; P Palumbo; S Rasheed; J Todd; M Vahey; P Reichelderfer
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

6.  The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements. The Women Infant Transmission Study Clinics. Virology Quality Assurance Program.

Authors:  D Brambilla; P S Reichelderfer; J W Bremer; D E Shapiro; R C Hershow; D A Katzenstein; S M Hammer; B Jackson; A C Collier; R S Sperling; M G Fowler; R W Coombs
Journal:  AIDS       Date:  1999-11-12       Impact factor: 4.177

7.  Clinical comparison of an enhanced-sensitivity branched-DNA assay and reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma.

Authors:  F S Nolte; J Boysza; C Thurmond; W S Clark; J L Lennox
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

8.  Use of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 to assess the performance of viral RNA quantitation tests.

Authors:  L L Jagodzinski; D L Wiggins; J L McManis; S Emery; J Overbaugh; M Robb; S Bodrug; N L Michael
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

Review 9.  Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.

Authors:  Patrick G Yeni; Scott M Hammer; Charles C J Carpenter; David A Cooper; Margaret A Fischl; Jose M Gatell; Brian G Gazzard; Martin S Hirsch; Donna M Jacobsen; David A Katzenstein; Julio S G Montaner; Douglas D Richman; Michael S Saag; Mauro Schechter; Robert T Schooley; Melanie A Thompson; Stefano Vella; Paul A Volberding
Journal:  JAMA       Date:  2002-07-10       Impact factor: 56.272

10.  Comparison of the QUANTIPLEX HIV-1 RNA 2.0 assay with the AMPLICOR HIV-1 MONITOR 1.0 assay for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma of patients receiving stavudine-didanosine combination therapy.

Authors:  M Segondy; J Izopet; I Pellegrin; B Montes; B Dumon; C Pasquier; M Peeters; H J Fleury; J Puel; J Reynes
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

View more
  3 in total

1.  Comparison of the sensitivities and viral load values of the AMPLICOR HIV-1 MONITOR version 1.0 and 1.5 tests.

Authors:  Angela M Caliendo; Jessica Ingersoll; Alicia M Green; Frederick S Nolte; Kirk A Easley
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

2.  Discordance between viral loads determined by Roche COBAS AMPLICOR human immunodeficiency virus type 1 monitor (version 1.5) Standard and ultrasensitive assays caused by freezing patient plasma in centrifuged becton-dickinson vacutainer brand plasma preparation tubes.

Authors:  Hossein Salimnia; Ellen C Moore; Lawrence R Crane; Rodger D Macarthur; Marilynn R Fairfax
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

3.  Multicenter performance evaluation of a new TaqMan PCR assay for monitoring human immunodeficiency virus RNA load.

Authors:  L Perrin; J M Pawlotsky; M Bouvier-Alias; C Sarrazin; S Zeuzem; G Colucci
Journal:  J Clin Microbiol       Date:  2006-09-27       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.